Mold-Tek Packaging Ltd Q4 FY24 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 1
Fundraise
Yes
Order
N/A
Capex
Yes
3 of 4 growth signals are positive.
Full analysisRevenue guidance
Category 3- Mold-Tek expects 10%-12% volume growth in the Paint segment driven by ABG addition (8%-10%) and new IML clients.
- Food & FMCG thin wall volumes targeted for 20% growth, supported by Panipat facility ramp-up from July-August.
- Qpack segment anticipated to grow 30%-40% in volumes, continuing strong momentum.
- Pharma segment, recently started commercial production, aims for INR20 crores turnover this year with a potential to double next year.
- Overall, volume growth guidance for FY25 remains double-digit, around 12%-14%.
- EBITDA margin expected to improve above 40% due to better capacity utilization and product mix shift towards higher-margin segments.
- Capacity additions planned cautiously; Mahad plant to start by October-November with INR15 crores investment, and potential further investments (~INR70 crores) depending on Pharma demand.
- Working capital utilization remains low, indicating capacity to support growth without capital strain.
See what Mold-Tek Packaging Ltd management said on margin guidance — free account, 30 seconds.
Fundraise plans
Yes- The company borrowed only INR 40 crores during the financial year but invested INR 140 crores, indicating no significant new borrowing.
- Working capital funds from the QIP proceeds were used to save interest costs, with unutilized working capital drawing power of about INR 100 crores and utilization around INR 69-70 crores.
- For the current year, planned capex is around INR 70 crores, mainly for Pharma and balancing equipment for IML and new plants, which is about half of last year's INR 140 crores investment.
- No specific mention of planned new fundraising via debt or equity was stated in the call.
- The company is focused on utilizing existing funds and drawing power efficiently rather than raising new funds immediately.
See what Mold-Tek Packaging Ltd management said on order book — free account, 30 seconds.
Capex plans
Yes- Current year capex is planned around INR 70 crores, primarily focused on Pharma, IML equipment, and Panipat thin wall plant.
- Mahad plant investment scheduled at about INR 15 crores in the first year; land already acquired, to start production this year.
- Further investments in Pharma packaging are dependent on market demand and client onboarding, with possible capacity expansion decisions around Q3.
- Recent years saw significant capacity additions; further additions will be need-based.
- Strategic focus on consolidating printing and die-cutting operations to reduce costs and wastage, with integration expected by July-August 2024.
- Pharma segment expected to drive higher growth, which may lead to increased capital investment if demand accelerates.
Track Mold-Tek Packaging Ltd — get its next earnings analysis in your feed
Margin guidance
Category 1- Mold-Tek Packaging expects double-digit volume growth of around 10-12% in the Paint segment for FY25, driven by new client additions like ABG and gains in IML segment.
- Pharma packaging is in a high-growth and high-value segment; commercial production began recently with strong demand and anticipated capacity utilization of 70-80% by Q3 FY25.
- Full-year Pharma revenue target for FY25 is around INR 20 crores, with potential to double next year due to growing client base and DMF standard adoption.
- EBITDA margin is expected to improve above 40% in FY25, up from 37.7% in FY24, driven by better product mix (Qpacks, Food & FMCG, Pharma) and higher capacity utilization.
- Medium-term volume growth expected between 4.8% to 15%+, supported strongly by ABG addition contributing ~7-10%.
- Pharma packaging growth could accelerate over the next few years as more clients adopt stringent packaging standards, potentially driving earnings and profitability significantly upward.
Order book
How does Mold-Tek Packaging Ltd rank vs peers in Industrial Products?
Pro featureHow does Mold-Tek Packaging Ltd rank in Industrial Products?
Compare Mold-Tek Packaging Ltd against every Industrial Products company (Q4 FY24) on revenue, margins and earnings-call signals.
Continue your research
What Mold-Tek Packaging Ltd's management said in earlier quarters
Others in Industrial Products this season
- Mitsu Chem Plast (Q1 FY27)
Q1 FY27 showed strong profitability with EBITDA margin improving to 16.29% and net profit margin to 9.18%. Key concall takeaways from Mitsu Chem Plast Ltd's Q1…
- Simplex Castings Ltd (Q1 FY27)
Current capacity expansion planned for 300-350 crores revenue, further growth through organic or inorganic expansion. Key concall takeaways from Simplex…
- Astral (Q1 FY27)
Q1 FY27 plumbing value growth: 10.1%; volume flat for the quarter but strong growth post-April (Page 6, 26) . Key concall takeaways from Astral Ltd's Q1 FY27…
- CPL (Q1 FY27)
Ramp-up of Ahmedabad manufacturing facility over next 2-3 years to support volume growth and improve margins by 1%-1.5%. Key concall takeaways from Captain…